Abstract
Deep brain stimulation of the subcallosal cingulate white matter (SCC DBS) has been investigated as a treatment for refractory depression since 2005. Results have generally been favorable in small-scale, open-label trials, but the 6-month outcomes of a randomized, sham-controlled trial appeared disappointing. However, given illness chronicity, the duration of typical efficacy trials may be inadequate to capture the impact of this intervention.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
